To quantify changes in protein expression of LNCaP-based cells upon re-expression of JAK1, cytokine treatment and/or infection, we applied SILAC to cells stimulated with IFNα or IL-6 and infected or not with EHDV-TAU. The gene discussed is JAK1; the disease is infection.